Elevation of fibrinogen and thrombin–antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy
Authors:
- Hideki AsakawaHAHideki Asakawa
- Katsuto TokunagaKTKatsuto Tokunaga
- Fusao KawakamiFKFusao Kawakami
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 14 (3) , 121-126
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fibrinogen and diabetes mellitus: is it time for intervention trials?Diabetologia, 1997
- Prothrombin Fragment 1 + 2 and Antithrombin III-Thrombin Complex in Microalbuminuric Type 2 Diabetic PatientsDiabetic Medicine, 1994
- Fibrinogen plasma levels as a marker of thrombin activation in diabetesDiabetes, 1994
- Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospectsDiabetologia, 1993
- Hyperfibrinogenemia: An important risk factor for vascular complications in diabetesDiabetes Care, 1992
- Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991
- Putative Risk Factors Associated with Retinopathy in Patients with Diabetes Diagnosed at or after 30 Years of AgeDiabetic Medicine, 1989
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levelsAtherosclerosis, 1986
- Risk Factors for Diabetic Retinopathy: A Population-Based Study in Rochester, MinnesotaDiabetes Care, 1986
- Diabetes, Blood Lipids, and the Role of Obesity in Coronary Heart Disease Risk for WomenAnnals of Internal Medicine, 1977